Therefore, targeting these translation factors alone or in their interactive complexes provides a platform to block the expression of mRNAs highly dependent on mRNA scanning, suggesting potentially improved cancer therapies for cancer involving upregulation or dependencies on eIF1 and eIF1A. This evidence concerns the gene EIF1 and cancer.